Nuohe Zhiyuan is a gene sequencing service provider, including scientific and technological services, tumor gene testing and gene testing. Detection services based on second-generation sequencing technology provide technical support for gene sequencing and bioinformatics for hospitals, pharmaceutical research and development enterprises, agricultural enterprises and other institutions. Provide patients with accurate treatment solutions such as tumor medication guidance, dynamic monitoring, and tumor genetic susceptibility gene detection.
More peer analysis, the company knows and understands.